Literature DB >> 24843117

Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.

Xavier Rodó1, Roger Curcoll2, Marguerite Robinson2, Joan Ballester3, Jane C Burns4, Daniel R Cayan5, W Ian Lipkin6, Brent L Williams6, Mara Couto-Rodriguez6, Yosikazu Nakamura7, Ritei Uehara7, Hiroshi Tanimoto8, Josep-Anton Morguí2.   

Abstract

Evidence indicates that the densely cultivated region of northeastern China acts as a source for the wind-borne agent of Kawasaki disease (KD). KD is an acute, coronary artery vasculitis of young children, and still a medical mystery after more than 40 y. We used residence times from simulations with the flexible particle dispersion model to pinpoint the source region for KD. Simulations were generated from locations spanning Japan from days with either high or low KD incidence. The postepidemic interval (1987-2010) and the extreme epidemics (1979, 1982, and 1986) pointed to the same source region. Results suggest a very short incubation period (<24 h) from exposure, thus making an infectious agent unlikely. Sampling campaigns over Japan during the KD season detected major differences in the microbiota of the tropospheric aerosols compared with ground aerosols, with the unexpected finding of the Candida species as the dominant fungus from aloft samples (54% of all fungal strains). These results, consistent with the Candida animal model for KD, provide support for the concept and feasibility of a windborne pathogen. A fungal toxin could be pursued as a possible etiologic agent of KD, consistent with an agricultural source, a short incubation time and synchronized outbreaks. Our study suggests that the causative agent of KD is a preformed toxin or environmental agent rather than an organism requiring replication. We propose a new paradigm whereby an idiosyncratic immune response, influenced by host genetics triggered by an environmental exposure carried on winds, results in the clinical syndrome known as acute KD.

Entities:  

Keywords:  FLEXPART; agriculture; cereal croplands; heart disease; northeastern China source

Mesh:

Substances:

Year:  2014        PMID: 24843117      PMCID: PMC4050536          DOI: 10.1073/pnas.1400380111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Refractory periods and climate forcing in cholera dynamics.

Authors:  Katia Koelle; Xavier Rodó; Mercedes Pascual; Md Yunus; Golam Mostafa
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

2.  Susceptibility loci to coronary arteritis in animal model of Kawasaki disease induced with Candida albicans -derived substances.

Authors:  Toshiaki Oharaseki; Yosuke Kameoka; Fumiaki Kura; Amanda S Persad; Kazuo Suzuki; Shiro Naoe
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

3.  Kawasaki disease in families.

Authors:  Y Fujita; Y Nakamura; K Sakata; N Hara; M Kobayashi; M Nagai; H Yanagawa; T Kawasaki
Journal:  Pediatrics       Date:  1989-10       Impact factor: 7.124

4.  IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease.

Authors:  A H Rowley; S T Shulman; C A Mask; L S Finn; M Terai; S C Baker; C A Galliani; K Takahashi; S Naoe; M B Kalelkar; S E Crawford
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

5.  Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Noriko N Miura; Naohito Ohno; Akiko I Okawara; Hisao Murata; Shiro Naoe; Kazuo Suzuki
Journal:  Mod Rheumatol       Date:  2009-11-27       Impact factor: 3.023

6.  Association of Kawasaki disease with tropospheric wind patterns.

Authors:  Xavier Rodó; Joan Ballester; Dan Cayan; Marian E Melish; Yoshikazu Nakamura; Ritei Uehara; Jane C Burns
Journal:  Sci Rep       Date:  2011-11-10       Impact factor: 4.379

7.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

8.  Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Joon-Sung Lee
Journal:  Med Hypotheses       Date:  2007-03-06       Impact factor: 1.538

9.  Finding Kawasaki disease.

Authors:  Jane C Burns
Journal:  Ann Pediatr Cardiol       Date:  2012-07

10.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31
View more
  62 in total

Review 1.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

2.  Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records.

Authors:  Rolando Cimaz; Eleonora Fanti; Angela Mauro; Fabio Voller; Franca Rusconi
Journal:  Eur J Pediatr       Date:  2017-06-14       Impact factor: 3.183

Review 3.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 4.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

5.  Kawasaki disease in Spanish paediatric population and synoptic weather types: an observational study.

Authors:  Leyre Riancho-Zarrabeitia; Domingo F Rasilla; Dominic Royé; Pablo Fdez-Arroyabe; Ana Santurtún
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

6.  Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?

Authors:  Rae Sm Yeung; Polly J Ferguson
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

7.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

8.  Soy isoflavone intake is associated with risk of Kawasaki disease.

Authors:  Michael A Portman; Sandi L Navarro; Margaret E Bruce; Johanna W Lampe
Journal:  Nutr Res       Date:  2016-04-12       Impact factor: 3.315

9.  Kawasaki disease: an epidemiological study in central Italy.

Authors:  Angela Mauro; Marianna Fabi; Monica Da Frè; Paolo Guastaroba; Elena Corinaldesi; Giovanni Battista Calabri; Teresa Giani; Gabriele Simonini; Franca Rusconi; Rolando Cimaz
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-12       Impact factor: 3.054

10.  Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.

Authors:  G Bossi; S Mannarino; M C Pietrogrande; P Salice; R M Dellepiane; A L Cremaschi; G Corana; A Tozzo; C Capittini; A De Silvestri; C Tinelli; A Pasi; M Martinetti
Journal:  Genes Immun       Date:  2015-09-03       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.